Week 14 Assignment 1: Interactive Thyroid Case Study

Answer the following questions in five well-developed paragraphs, integrating five evidence-based resources to include clinical practice guidelines and the course textbook. Provides clear examples supported by course content and references, and citations

Cites three or more references, using at least three new scholarly resources within five years from 2023, including clinical practice guidelines, as well as the course textbook. That were not provided in the course materials. Please provide an exact dose for the chosen medications, route of administration, and frequency.

Woo, T. M., & Robinson, M. V. (2020). Pharmacotherapeutics for advanced practice nurse prescribers (5th ed.). Philadelphia, PA: F.A. Davis Company.

Maria is a 29-year-old woman with a seven-month history of heavy, irregular menses, a 5-lb weight gain, constipation, and decreased energy. Her past history is unremarkable. She takes no prescription medications but uses iron and calcium supplements. She has a family history of thyroid disease. On examination, her weight is 152 lbs, her heart rate is 64 bpm, and her blood pressure is 138/86. Her thyroid gland is mildly enlarged, without nodularity. She has trace edema in her lower extremities, and her reflexes are slow.

Laboratory studies are as follows:

TSH is 15.3 mIU/mL (elevated), free T4 is 0.3 mIU/mL (decreased), and total cholesterol is 276 mg/mL.

Diagnosis: Primary Hypothyroidism

Please answer all of the following questions with rationale, explanation, and citations.

1. List specific goals of treatment for Maria.

2. What drug therapy would you prescribe? Why?

3. What are the parameters for monitoring the success of the therapy?

4. Discuss specific patient education based on the prescribed therapy.

5. List one or two adverse reactions for the selected agent that would cause you to change therapy.

6. What would be the choice for second-line therapy?

7. What over-the-counter and/or alternative medications would be appropriate for Maria?

8. What lifestyle changes would you recommend to Maria?

9. Describe one or two drug-drug or drug-food interactions for the selected agent.

Note: Acceptable Resources

Textbooks Not later than 5 years from (2023)

Peer-reviewed journal articles:

o New England Journal of Medicine

o Diabetes Educator

o Journal of the American Association of Nurse Practitioners

o UpToDate with an author

o Epocrates – Drug information

Unacceptable Resources:

WebMD · (you may use the Pro edition)

Drugs.com (you may use the Pro edition)

Emedicine.com ·

Dynamed ·

Healthline

Statpearls

Medscape

MedlinePlus

Blogs of any type

Mayo Clinic & Cleveland Clinic websites are opinions, not evidence-based.

Medical News Today

Materials aimed at the “lay” person (consumer-level websites are not peer-reviewed and written on an eighth grade education level). Any website with the word ‘consumer’ in its title, discussion of what the website provides, etc.

ANSWER

Interactive Thyroid Case Study: Evidence-Based Approach to Treatment

Maria, a 29-year-old woman, presents with a seven-month history of heavy, irregular menses, a 5-lb weight gain, constipation, decreased energy, and a family history of thyroid disease. Examination reveals an enlarged thyroid gland, slow reflexes, and trace edema in her lower extremities. Laboratory results indicate an elevated TSH of 15.3 mIU/mL and decreased free T4 of 0.3 mIU/mL, leading to the diagnosis of primary hypothyroidism. To formulate an evidence-based treatment plan for Maria, this case study addresses specific goals of treatment, drug therapy, monitoring parameters, patient education, adverse reactions, second-line therapy, over-the-counter medications, lifestyle changes, and drug interactions.

Goals of Treatment:Specific goals for Maria’s treatment include restoring euthyroidism, improving symptoms, and preventing complications such as cardiovascular disease (Woo & Robinson, 2020). Normalizing TSH and free T4 levels is essential to achieving these goals and improving her quality of life.

Drug Therapy: Levothyroxine is the drug of choice for primary hypothyroidism. It provides synthetic T4 replacement and helps normalize thyroid hormone levels (Woo & Robinson, 2020). The initial dose should be 1.6 mcg/kg/day, based on her weight, administered orally on an empty stomach in the morning.

Monitoring Parameters: Success of therapy is evaluated by monitoring TSH and free T4 levels, which should return to within the normal range. TSH levels are typically rechecked in 4-6 weeks, with adjustments made in dose if necessary (Woo & Robinson, 2020).

Patient Education: Maria should be educated about the importance of consistent medication administration and the need for lifelong therapy. She should understand that improvement in symptoms may take several weeks.

Adverse Reactions: One adverse reaction that might prompt a therapy change is cardiac arrhythmias, indicating overmedication. Another is symptoms of hyperthyroidism, such as nervousness and insomnia (Woo & Robinson, 2020).

Second-Line Therapy: If levothyroxine is not well-tolerated or if Maria prefers an alternative, desiccated thyroid extract can be considered. However, it is less preferred due to inconsistency in hormone content.

Over-the-Counter Medications: Calcium supplements and iron supplements, which Maria uses, can interfere with levothyroxine absorption. She should be educated about separating these supplements by at least 4 hours from her medication (Woo & Robinson, 2020).

Lifestyle Changes: Maria should be advised to maintain a balanced diet, engage in regular physical activity, and ensure adequate sleep. Lifestyle modifications can help optimize her metabolism and energy levels.

Drug Interactions: Maria should be cautious about interactions with antacids, calcium supplements, and certain medications (e.g., proton pump inhibitors) that can decrease levothyroxine absorption. She should be instructed to take levothyroxine on an empty stomach and avoid taking it with these agents (Woo & Robinson, 2020).

In conclusion, an evidence-based approach to treating Maria’s primary hypothyroidism involves the use of levothyroxine to normalize thyroid hormone levels, improve symptoms, and prevent complications. Monitoring TSH and free T4 levels, educating the patient, and addressing adverse reactions and potential interactions are essential components of her comprehensive care plan.